Micro/nanorobot physical stimulation: from mechanisms to precision therapeutics
Nanoscale · 2026
DOI: 10.1039/d6nr01446a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2026. Verfasst von Xiaoyu Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intelligent Materials and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. taoyang@seu.edu.cn. Hauptthemen laut MEDLINE: Drug Delivery Systems, Precision Medicine. Die Arbeit nennt 176 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
This article overviews recent progress on physical stimulations assisted with micro/nanorobots, particularly on cell fate regulations and their promising applications in neurological systems, non-neuronal tissues, and targeted tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Intelligent Materials and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. taoyang@seu.edu.cn.
- School of Intelligent Science and Engineering, Wuxi 214026, China.
- Materials Science Graduate Program, Kent State University, Kent, Ohio 44242.
Förderung
- Basic Research Program of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Yang, T., & Li, Q. (2026). Micro/nanorobot physical stimulation: from mechanisms to precision therapeutics. Nanoscale. https://doi.org/10.1039/d6nr01446a
Vancouver
Wang X, Yang T, Li Q. Micro/nanorobot physical stimulation: from mechanisms to precision therapeutics. Nanoscale. 2026. doi:10.1039/d6nr01446a
BibTeX
@article{Wang2026,
author = {Wang, Xiaoyu and Yang, Tao and Li, Quan},
title = {Micro/nanorobot physical stimulation: from mechanisms to precision therapeutics},
journal = {Nanoscale},
year = {2026},
doi = {10.1039/d6nr01446a}
}
EUVIMED